Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.
Barbara E StähliFerdinando VarbellaAxel LinkeBettina SchwarzStephan B FelixMoritz SeiffertRahel KesterkePeter NordbeckBernhard WitzenbichlerIrene M LangMirjam KesslerChristian ValinaAlban DibraMiklos RohlaMarco MoccettiMatteo VercellinoLuise GaedeLorenz Bott-FlügelPhilipp JakobJulia StehliAlessandro CandrevaChristian TemplinMatthias SchindlerManfred WischnewskyGreca ZandaGiorgio QuadriNorman MangnerAurel TomaGiulia MagnaniPeter ClemmensenThomas F LüscherThomas MunzelP Christian SchulzeKarl-Ludwig LaugwitzWolfgang RottbauerKurt HuberFranz-Josef NeumannSteffen SchneiderFranz WeidingerStephan AchenbachGert RichardtAdnan KastratiIan FordWillibald MaierFrank Ruschitzkanull nullPublished in: The New England journal of medicine (2023)
Among patients in hemodynamically stable condition with STEMI and multivessel coronary artery disease, immediate multivessel PCI was noninferior to staged multivessel PCI with respect to the risk of death from any cause, nonfatal myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization for heart failure at 1 year. (Supported by Boston Scientific; MULTISTARS AMI ClinicalTrials.gov number, NCT03135275.).
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- heart failure
- coronary artery bypass grafting
- antiplatelet therapy
- atrial fibrillation
- acute coronary syndrome
- left ventricular
- coronary artery bypass
- cardiovascular events
- cardiac resynchronization therapy
- cardiovascular disease
- acute heart failure